JP2006507807A - ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 - Google Patents
ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 Download PDFInfo
- Publication number
- JP2006507807A JP2006507807A JP2004524480A JP2004524480A JP2006507807A JP 2006507807 A JP2006507807 A JP 2006507807A JP 2004524480 A JP2004524480 A JP 2004524480A JP 2004524480 A JP2004524480 A JP 2004524480A JP 2006507807 A JP2006507807 A JP 2006507807A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- gene
- sequence number
- cell
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 764
- 208000036142 Viral infection Diseases 0.000 title claims abstract description 73
- 230000009385 viral infection Effects 0.000 title claims abstract description 73
- 230000005760 tumorsuppression Effects 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 238
- 241000700605 Viruses Species 0.000 claims abstract description 144
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 122
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 114
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 114
- 230000001413 cellular effect Effects 0.000 claims abstract description 66
- 230000004083 survival effect Effects 0.000 claims abstract description 48
- 230000012010 growth Effects 0.000 claims abstract description 38
- 210000004027 cell Anatomy 0.000 claims description 485
- 102000004169 proteins and genes Human genes 0.000 claims description 206
- 239000002773 nucleotide Substances 0.000 claims description 113
- 125000003729 nucleotide group Chemical group 0.000 claims description 113
- 230000014509 gene expression Effects 0.000 claims description 109
- 210000002966 serum Anatomy 0.000 claims description 109
- 239000013598 vector Substances 0.000 claims description 58
- 239000003550 marker Substances 0.000 claims description 51
- 108010014064 CCCTC-Binding Factor Proteins 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 49
- 150000001875 compounds Chemical class 0.000 claims description 45
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 44
- 238000004113 cell culture Methods 0.000 claims description 39
- 230000001105 regulatory effect Effects 0.000 claims description 31
- 230000002401 inhibitory effect Effects 0.000 claims description 30
- 230000002018 overexpression Effects 0.000 claims description 29
- 238000012216 screening Methods 0.000 claims description 29
- 230000003211 malignant effect Effects 0.000 claims description 28
- 230000002829 reductive effect Effects 0.000 claims description 24
- 229920001817 Agar Polymers 0.000 claims description 19
- 239000008272 agar Substances 0.000 claims description 19
- 238000011282 treatment Methods 0.000 claims description 19
- 230000001965 increasing effect Effects 0.000 claims description 18
- 230000009467 reduction Effects 0.000 claims description 17
- 206010028980 Neoplasm Diseases 0.000 claims description 15
- 230000029812 viral genome replication Effects 0.000 claims description 15
- 108700008625 Reporter Genes Proteins 0.000 claims description 14
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 14
- 239000003184 complementary RNA Substances 0.000 claims description 13
- 239000003112 inhibitor Substances 0.000 claims description 13
- 108020005544 Antisense RNA Proteins 0.000 claims description 12
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 7
- 230000008030 elimination Effects 0.000 claims description 6
- 238000003379 elimination reaction Methods 0.000 claims description 6
- 102000016897 CCCTC-Binding Factor Human genes 0.000 claims description 3
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 claims 1
- 102100025947 Insulin-like growth factor II Human genes 0.000 claims 1
- 230000008034 disappearance Effects 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 abstract description 32
- 230000008569 process Effects 0.000 abstract description 23
- 244000045947 parasite Species 0.000 abstract description 14
- 206010061309 Neoplasm progression Diseases 0.000 abstract description 7
- 230000001580 bacterial effect Effects 0.000 abstract description 7
- 230000005751 tumor progression Effects 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 6
- 208000030852 Parasitic disease Diseases 0.000 abstract description 5
- 208000035143 Bacterial infection Diseases 0.000 abstract description 4
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 description 198
- 241000282414 Homo sapiens Species 0.000 description 83
- 239000000047 product Substances 0.000 description 78
- 239000002299 complementary DNA Substances 0.000 description 65
- 208000015181 infectious disease Diseases 0.000 description 62
- 230000027455 binding Effects 0.000 description 46
- 102100027671 Transcriptional repressor CTCF Human genes 0.000 description 45
- 241000699666 Mus <mouse, genus> Species 0.000 description 44
- 108020004999 messenger RNA Proteins 0.000 description 41
- 238000004458 analytical method Methods 0.000 description 40
- 230000035772 mutation Effects 0.000 description 39
- 241000702263 Reovirus sp. Species 0.000 description 37
- 229940024606 amino acid Drugs 0.000 description 37
- 235000001014 amino acid Nutrition 0.000 description 34
- 230000000694 effects Effects 0.000 description 33
- 230000006870 function Effects 0.000 description 33
- 150000001413 amino acids Chemical class 0.000 description 32
- 210000000349 chromosome Anatomy 0.000 description 32
- 241000700159 Rattus Species 0.000 description 29
- 230000002068 genetic effect Effects 0.000 description 29
- 239000002609 medium Substances 0.000 description 29
- 239000000523 sample Substances 0.000 description 29
- 108050008874 Annexin Proteins 0.000 description 28
- 102000000412 Annexin Human genes 0.000 description 27
- 108090000765 processed proteins & peptides Proteins 0.000 description 26
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 25
- 230000037361 pathway Effects 0.000 description 25
- 210000001519 tissue Anatomy 0.000 description 25
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 24
- 239000012634 fragment Substances 0.000 description 22
- 238000009396 hybridization Methods 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 21
- 108020004459 Small interfering RNA Proteins 0.000 description 21
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- 230000000692 anti-sense effect Effects 0.000 description 21
- 108010030743 Tropomyosin Proteins 0.000 description 20
- 102000004506 Blood Proteins Human genes 0.000 description 19
- 108010017384 Blood Proteins Proteins 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 19
- 102000049873 Smad7 Human genes 0.000 description 19
- 239000004055 small Interfering RNA Substances 0.000 description 19
- 230000004913 activation Effects 0.000 description 18
- 230000000295 complement effect Effects 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 18
- 238000010561 standard procedure Methods 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 17
- 238000000636 Northern blotting Methods 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 238000007901 in situ hybridization Methods 0.000 description 17
- 102000004196 processed proteins & peptides Human genes 0.000 description 17
- 102100039436 DNA-binding protein inhibitor ID-3 Human genes 0.000 description 16
- 201000010099 disease Diseases 0.000 description 16
- 230000002101 lytic effect Effects 0.000 description 16
- 229920001184 polypeptide Polymers 0.000 description 16
- 238000012163 sequencing technique Methods 0.000 description 16
- 102100022343 Protein phosphatase 1A Human genes 0.000 description 15
- 102100021228 TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 Human genes 0.000 description 15
- 101710178958 TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 Proteins 0.000 description 15
- 102000005937 Tropomyosin Human genes 0.000 description 15
- 102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 108091026890 Coding region Proteins 0.000 description 14
- 230000000875 corresponding effect Effects 0.000 description 14
- 238000003780 insertion Methods 0.000 description 14
- 230000037431 insertion Effects 0.000 description 14
- 108700028369 Alleles Proteins 0.000 description 13
- 102100022258 Disks large homolog 5 Human genes 0.000 description 13
- 102100032421 Protein S100-A6 Human genes 0.000 description 13
- 238000012217 deletion Methods 0.000 description 13
- 230000037430 deletion Effects 0.000 description 13
- 230000001419 dependent effect Effects 0.000 description 13
- 239000003623 enhancer Substances 0.000 description 13
- 102100033672 Deleted in azoospermia-like Human genes 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 101000915402 Homo sapiens Deleted in azoospermia protein 1 Proteins 0.000 description 12
- 101000620650 Homo sapiens Protein phosphatase 1A Proteins 0.000 description 12
- 241000725303 Human immunodeficiency virus Species 0.000 description 12
- 108091034117 Oligonucleotide Proteins 0.000 description 12
- 108010005260 S100 Calcium Binding Protein A6 Proteins 0.000 description 12
- 101700026522 SMAD7 Proteins 0.000 description 12
- 108091023040 Transcription factor Proteins 0.000 description 12
- 230000006907 apoptotic process Effects 0.000 description 12
- 238000000338 in vitro Methods 0.000 description 12
- 230000002779 inactivation Effects 0.000 description 12
- 238000002955 isolation Methods 0.000 description 12
- 210000004962 mammalian cell Anatomy 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000035897 transcription Effects 0.000 description 12
- 238000013518 transcription Methods 0.000 description 12
- 108700024394 Exon Proteins 0.000 description 11
- 102100028818 Heterogeneous nuclear ribonucleoprotein L Human genes 0.000 description 11
- 101000871280 Homo sapiens Deleted in azoospermia-like Proteins 0.000 description 11
- 101000839078 Homo sapiens Heterogeneous nuclear ribonucleoprotein L Proteins 0.000 description 11
- 102000043136 MAP kinase family Human genes 0.000 description 11
- 108091054455 MAP kinase family Proteins 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 102100021119 Serine protease HTRA1 Human genes 0.000 description 11
- 102000040945 Transcription factor Human genes 0.000 description 11
- 101710128188 Tropomyosin alpha-1 chain Proteins 0.000 description 11
- 101710186379 Tropomyosin-1 Proteins 0.000 description 11
- 230000022131 cell cycle Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 11
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 11
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 241001430294 unidentified retrovirus Species 0.000 description 11
- 102100028574 Deleted in azoospermia protein 1 Human genes 0.000 description 10
- 102100040022 Eukaryotic translation initiation factor 4 gamma 3 Human genes 0.000 description 10
- 108020004202 Guanylate Kinase Proteins 0.000 description 10
- 101100063489 Homo sapiens DLG5 gene Proteins 0.000 description 10
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 10
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 10
- 108700026244 Open Reading Frames Proteins 0.000 description 10
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 10
- 101710122555 Signal recognition particle 19 kDa protein Proteins 0.000 description 10
- 102100027388 Signal recognition particle 19 kDa protein Human genes 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
- 102000006638 guanylate kinase Human genes 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 230000001404 mediated effect Effects 0.000 description 10
- 102000005962 receptors Human genes 0.000 description 10
- 108020003175 receptors Proteins 0.000 description 10
- 230000001177 retroviral effect Effects 0.000 description 10
- 229910052725 zinc Inorganic materials 0.000 description 10
- 239000011701 zinc Substances 0.000 description 10
- 108010072220 Cyclophilin A Proteins 0.000 description 9
- 101710152064 DNA-binding protein inhibitor ID-3 Proteins 0.000 description 9
- 101001041393 Homo sapiens Serine protease HTRA1 Proteins 0.000 description 9
- 101150047228 Id3 gene Proteins 0.000 description 9
- 101150002416 Igf2 gene Proteins 0.000 description 9
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 9
- 239000002502 liposome Substances 0.000 description 9
- 230000019491 signal transduction Effects 0.000 description 9
- 210000002027 skeletal muscle Anatomy 0.000 description 9
- 108091008743 testicular receptors 4 Proteins 0.000 description 9
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 8
- 102000021350 Caspase recruitment domains Human genes 0.000 description 8
- 108091011189 Caspase recruitment domains Proteins 0.000 description 8
- 108700036184 Eukaryotic translation initiation factor 4 gamma 3 Proteins 0.000 description 8
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 8
- 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 102100036978 Peptidyl-prolyl cis-trans isomerase FKBP8 Human genes 0.000 description 8
- 208000008104 Reoviridae Infections Diseases 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000003642 hunger Nutrition 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 230000010076 replication Effects 0.000 description 8
- 239000012679 serum free medium Substances 0.000 description 8
- 230000037351 starvation Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 7
- 102100032248 Dysferlin Human genes 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 101100340262 Homo sapiens ID3 gene Proteins 0.000 description 7
- 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 7
- 229930193140 Neomycin Natural products 0.000 description 7
- 101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 description 7
- 101100335937 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gas5 gene Proteins 0.000 description 7
- 210000001744 T-lymphocyte Anatomy 0.000 description 7
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 7
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 7
- 102100027389 Tyrosine-protein kinase HCK Human genes 0.000 description 7
- 101150082045 U3 gene Proteins 0.000 description 7
- 108010070113 alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000004899 c-terminal region Anatomy 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 101150077246 gas5 gene Proteins 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 7
- 210000003917 human chromosome Anatomy 0.000 description 7
- 230000002458 infectious effect Effects 0.000 description 7
- 239000012212 insulator Substances 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000011987 methylation Effects 0.000 description 7
- 238000007069 methylation reaction Methods 0.000 description 7
- 229960004927 neomycin Drugs 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000035882 stress Effects 0.000 description 7
- 206010001935 American trypanosomiasis Diseases 0.000 description 6
- 102100034524 Apoptotic protease-activating factor 1 Human genes 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 102100038796 E3 ubiquitin-protein ligase TRIM13 Human genes 0.000 description 6
- 208000031886 HIV Infections Diseases 0.000 description 6
- 101150007028 HTRA1 gene Proteins 0.000 description 6
- 101000924629 Homo sapiens Apoptotic protease-activating factor 1 Proteins 0.000 description 6
- 101001009087 Homo sapiens Tyrosine-protein kinase HCK Proteins 0.000 description 6
- 102000050704 Nod1 Signaling Adaptor Human genes 0.000 description 6
- 108700002046 Nod1 Signaling Adaptor Proteins 0.000 description 6
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 6
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 6
- 108010029485 Protein Isoforms Proteins 0.000 description 6
- 102000001708 Protein Isoforms Human genes 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 241000223109 Trypanosoma cruzi Species 0.000 description 6
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 210000004748 cultured cell Anatomy 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- 210000002889 endothelial cell Anatomy 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 210000004165 myocardium Anatomy 0.000 description 6
- 230000026731 phosphorylation Effects 0.000 description 6
- 238000006366 phosphorylation reaction Methods 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 241000712461 unidentified influenza virus Species 0.000 description 6
- 102100039958 BUB3-interacting and GLEBS motif-containing protein ZNF207 Human genes 0.000 description 5
- 101710114250 BUB3-interacting and GLEBS motif-containing protein ZNF207 Proteins 0.000 description 5
- 101150050847 CPA2 gene Proteins 0.000 description 5
- 230000004568 DNA-binding Effects 0.000 description 5
- 241000255925 Diptera Species 0.000 description 5
- 102000012858 Eukaryotic Initiation Factor-4G Human genes 0.000 description 5
- 108010057192 Eukaryotic Initiation Factor-4G Proteins 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 101000664589 Homo sapiens E3 ubiquitin-protein ligase TRIM13 Proteins 0.000 description 5
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 5
- 101000652174 Homo sapiens Mothers against decapentaplegic homolog 6 Proteins 0.000 description 5
- 101000605127 Homo sapiens Prostaglandin G/H synthase 2 Proteins 0.000 description 5
- 101000869703 Homo sapiens Protein S100-A6 Proteins 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 5
- 101150106914 LOX1 gene Proteins 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 5
- 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 5
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 5
- 101150005821 Nod1 gene Proteins 0.000 description 5
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 102000004389 Ribonucleoproteins Human genes 0.000 description 5
- 108010081734 Ribonucleoproteins Proteins 0.000 description 5
- 102000012479 Serine Proteases Human genes 0.000 description 5
- 108010022999 Serine Proteases Proteins 0.000 description 5
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 5
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 5
- 102000003436 UBA3 Human genes 0.000 description 5
- 108060008744 UBA3 Proteins 0.000 description 5
- 102000044159 Ubiquitin Human genes 0.000 description 5
- 108090000848 Ubiquitin Proteins 0.000 description 5
- 230000035508 accumulation Effects 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 101150113125 cpa-1 gene Proteins 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 108090000743 multidrug resistance protein 3 Proteins 0.000 description 5
- 102000004233 multidrug resistance protein 3 Human genes 0.000 description 5
- 210000003757 neuroblast Anatomy 0.000 description 5
- 210000000440 neutrophil Anatomy 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 230000002085 persistent effect Effects 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 210000002307 prostate Anatomy 0.000 description 5
- 238000012340 reverse transcriptase PCR Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 230000004614 tumor growth Effects 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 108091006112 ATPases Proteins 0.000 description 4
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 4
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 208000031229 Cardiomyopathies Diseases 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- 208000024699 Chagas disease Diseases 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 101150011616 Ctcf gene Proteins 0.000 description 4
- 229930105110 Cyclosporin A Natural products 0.000 description 4
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
- 108010036949 Cyclosporine Proteins 0.000 description 4
- 230000007067 DNA methylation Effects 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 108090000620 Dysferlin Proteins 0.000 description 4
- 241000709661 Enterovirus Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 101100403712 Gallus gallus MYC gene Proteins 0.000 description 4
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 4
- 101000902114 Homo sapiens Disks large homolog 5 Proteins 0.000 description 4
- 101000664952 Homo sapiens E3 ubiquitin-protein ligase SMURF2 Proteins 0.000 description 4
- 101000725972 Homo sapiens Transcriptional repressor CTCF Proteins 0.000 description 4
- 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 4
- 101000801701 Homo sapiens Tropomyosin alpha-1 chain Proteins 0.000 description 4
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 4
- 102000019145 JUN kinase activity proteins Human genes 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- 101150098959 MON1 gene Proteins 0.000 description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
- 102100022437 Myotonin-protein kinase Human genes 0.000 description 4
- 102100031911 NEDD8 Human genes 0.000 description 4
- 108700004934 NEDD8 Proteins 0.000 description 4
- 101150107958 NEDD8 gene Proteins 0.000 description 4
- 101100291875 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) apg-13 gene Proteins 0.000 description 4
- 101100532088 Oryza sativa subsp. japonica RUB2 gene Proteins 0.000 description 4
- 101100532090 Oryza sativa subsp. japonica RUB3 gene Proteins 0.000 description 4
- 101710199789 Oxidized low-density lipoprotein receptor 1 Proteins 0.000 description 4
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 4
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 230000004570 RNA-binding Effects 0.000 description 4
- 108010079933 Receptor-Interacting Protein Serine-Threonine Kinase 2 Proteins 0.000 description 4
- 102100022502 Receptor-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 4
- 101150048952 TPM-1 gene Proteins 0.000 description 4
- 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 229960001265 ciclosporin Drugs 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000005546 dideoxynucleotide Substances 0.000 description 4
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- 102000047275 human CTCF Human genes 0.000 description 4
- 201000010565 hypertrophic cardiomyopathy 3 Diseases 0.000 description 4
- 238000003119 immunoblot Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 101710098598 mRNA decay activator protein ZFP36 Proteins 0.000 description 4
- 102100031622 mRNA decay activator protein ZFP36 Human genes 0.000 description 4
- 108010082117 matrigel Proteins 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 101150024074 rub1 gene Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 102100027123 55 kDa erythrocyte membrane protein Human genes 0.000 description 3
- 102100032123 AMP deaminase 1 Human genes 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 101000916329 Agrobacterium vitis Uncharacterized HTH-type transcriptional regulator in the TAR-I ttuE-ttuC' intergenic region Proteins 0.000 description 3
- 102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 description 3
- 102000004149 Annexin A2 Human genes 0.000 description 3
- 108090000668 Annexin A2 Proteins 0.000 description 3
- 102000004120 Annexin A3 Human genes 0.000 description 3
- 108090000670 Annexin A3 Proteins 0.000 description 3
- 101000708515 Arabidopsis thaliana Uncharacterized tatC-like protein ymf16 Proteins 0.000 description 3
- 241000271566 Aves Species 0.000 description 3
- 101000762568 Bacillus subtilis (strain 168) Uncharacterized oxidoreductase YhxC Proteins 0.000 description 3
- 101000786181 Bacillus subtilis (strain 168) Uncharacterized protein YppC Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 101100462144 Bos taurus OLR1 gene Proteins 0.000 description 3
- 102100033641 Bromodomain-containing protein 2 Human genes 0.000 description 3
- 102100033642 Bromodomain-containing protein 3 Human genes 0.000 description 3
- 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 3
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 3
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 3
- 102100026550 Caspase-9 Human genes 0.000 description 3
- 244000045195 Cicer arietinum Species 0.000 description 3
- 235000010523 Cicer arietinum Nutrition 0.000 description 3
- 101000950885 Citrobacter freundii Probable glycerol dehydratase-reactivating factor small subunit Proteins 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- 101000751046 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) Uncharacterized protein Cgl0250/cg0304 Proteins 0.000 description 3
- 230000005778 DNA damage Effects 0.000 description 3
- 231100000277 DNA damage Toxicity 0.000 description 3
- 101100507775 Danio rerio htra1a gene Proteins 0.000 description 3
- 102000036292 Death effector domains Human genes 0.000 description 3
- 108091010866 Death effector domains Proteins 0.000 description 3
- 102100038662 E3 ubiquitin-protein ligase SMURF2 Human genes 0.000 description 3
- 101000787036 Escherichia coli (strain K12) Uncharacterized protein YhaC Proteins 0.000 description 3
- 108010089790 Eukaryotic Initiation Factor-3 Proteins 0.000 description 3
- 102100034295 Eukaryotic translation initiation factor 3 subunit A Human genes 0.000 description 3
- 241000713800 Feline immunodeficiency virus Species 0.000 description 3
- 101000847695 Helicobacter pylori (strain ATCC 700392 / 26695) Uncharacterized protein HP_1070 Proteins 0.000 description 3
- 101000871851 Homo sapiens Bromodomain-containing protein 3 Proteins 0.000 description 3
- 101000725401 Homo sapiens Cytochrome c oxidase subunit 2 Proteins 0.000 description 3
- 101001016184 Homo sapiens Dysferlin Proteins 0.000 description 3
- 101001062347 Homo sapiens Hepatocyte nuclear factor 3-beta Proteins 0.000 description 3
- 101000840577 Homo sapiens Insulin-like growth factor-binding protein 7 Proteins 0.000 description 3
- 101000962483 Homo sapiens Max dimerization protein 1 Proteins 0.000 description 3
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 3
- 101001030243 Homo sapiens Myosin-7 Proteins 0.000 description 3
- 101000722029 Homo sapiens Oxidized low-density lipoprotein receptor 1 Proteins 0.000 description 3
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 3
- 108010031792 IGF Type 2 Receptor Proteins 0.000 description 3
- 102000038460 IGF Type 2 Receptor Human genes 0.000 description 3
- 102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 description 3
- 101150014436 LOX1.1 gene Proteins 0.000 description 3
- 101000747699 Lactococcus lactis subsp. lactis Uncharacterized 9.7 kDa protein in lcnC 5'region Proteins 0.000 description 3
- 102100037611 Lysophospholipase Human genes 0.000 description 3
- 241001480504 Mammalian orthoreovirus 1 Species 0.000 description 3
- 101000805242 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) Uncharacterized protein MTBMA_c00490 Proteins 0.000 description 3
- 101150030635 Mgat1 gene Proteins 0.000 description 3
- 241000699660 Mus musculus Species 0.000 description 3
- 101000823660 Mycolicibacterium smegmatis Uncharacterized 15.4 kDa protein in ask 5'region Proteins 0.000 description 3
- 102100038934 Myosin-7 Human genes 0.000 description 3
- 102100028719 NEDD8-activating enzyme E1 catalytic subunit Human genes 0.000 description 3
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 3
- 101150086211 OLR1 gene Proteins 0.000 description 3
- 108010028191 Oxidized LDL Receptors Proteins 0.000 description 3
- 208000037581 Persistent Infection Diseases 0.000 description 3
- 101100455173 Phaseolus vulgaris LOXA gene Proteins 0.000 description 3
- 108010058864 Phospholipases A2 Proteins 0.000 description 3
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 3
- 102100032420 Protein S100-A9 Human genes 0.000 description 3
- 101710105644 Protein phosphatase 1A Proteins 0.000 description 3
- 108700005075 Regulator Genes Proteins 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 102100037082 Signal recognition particle 14 kDa protein Human genes 0.000 description 3
- 101710089523 Signal recognition particle 14 kDa protein Proteins 0.000 description 3
- 101710187184 Signal recognition particle 54 kDa protein Proteins 0.000 description 3
- 102100031877 Signal recognition particle 54 kDa protein Human genes 0.000 description 3
- 101710150385 Signal recognition particle 54 kDa protein 1 Proteins 0.000 description 3
- 101710150383 Signal recognition particle 54 kDa protein 2 Proteins 0.000 description 3
- 101710150391 Signal recognition particle 54 kDa protein 3 Proteins 0.000 description 3
- 101710128823 Signal recognition particle 54 kDa protein homolog Proteins 0.000 description 3
- 102100022055 Signal recognition particle 9 kDa protein Human genes 0.000 description 3
- 101710131307 Signal recognition particle 9 kDa protein Proteins 0.000 description 3
- 101100182222 Solanum tuberosum LOX1.2 gene Proteins 0.000 description 3
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 3
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 108090001108 Troponin T Proteins 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000036952 cancer formation Effects 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000025084 cell cycle arrest Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000000749 co-immunoprecipitation Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 230000002939 deleterious effect Effects 0.000 description 3
- 230000030609 dephosphorylation Effects 0.000 description 3
- 238000006209 dephosphorylation reaction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 238000010230 functional analysis Methods 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 3
- 102000052513 human OLR1 Human genes 0.000 description 3
- 206010020871 hypertrophic cardiomyopathy Diseases 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000011813 knockout mouse model Methods 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000002132 lysosomal effect Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000036457 multidrug resistance Effects 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 210000003365 myofibril Anatomy 0.000 description 3
- 201000009340 myotonic dystrophy type 1 Diseases 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 238000012261 overproduction Methods 0.000 description 3
- 230000008775 paternal effect Effects 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 210000001995 reticulocyte Anatomy 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 230000021595 spermatogenesis Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 238000001086 yeast two-hybrid system Methods 0.000 description 3
- 102100028505 6-pyruvoyl tetrahydrobiopterin synthase Human genes 0.000 description 2
- 108010045523 6-pyruvoyltetrahydropterin synthase Proteins 0.000 description 2
- 108700001666 APC Genes Proteins 0.000 description 2
- 101001082110 Acanthamoeba polyphaga mimivirus Eukaryotic translation initiation factor 4E homolog Proteins 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 108010049777 Ankyrins Proteins 0.000 description 2
- 102000008102 Ankyrins Human genes 0.000 description 2
- 102000004145 Annexin A1 Human genes 0.000 description 2
- 108090000663 Annexin A1 Proteins 0.000 description 2
- 101100532518 Arabidopsis thaliana SAHH1 gene Proteins 0.000 description 2
- 101710126816 Bromodomain-containing protein 2 Proteins 0.000 description 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
- 102000002164 CARD domains Human genes 0.000 description 2
- 108050009503 CARD domains Proteins 0.000 description 2
- 101710100501 CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 2
- 101100173542 Caenorhabditis elegans fer-1 gene Proteins 0.000 description 2
- 108010052495 Calgranulin B Proteins 0.000 description 2
- 102000000584 Calmodulin Human genes 0.000 description 2
- 108010041952 Calmodulin Proteins 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 101710159037 Cleavage stimulation factor subunit 2 Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 2
- 101150051240 DLX2 gene Proteins 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 101001082109 Danio rerio Eukaryotic translation initiation factor 4E-1B Proteins 0.000 description 2
- 102100038713 Death domain-containing protein CRADD Human genes 0.000 description 2
- 108050006472 Deleted in azoospermia-like Proteins 0.000 description 2
- 108700013083 Drosophila dlg1 Proteins 0.000 description 2
- 101100232687 Drosophila melanogaster eIF4A gene Proteins 0.000 description 2
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 2
- 101710146518 Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 2
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 2
- 208000037150 Dysferlin-related limb-girdle muscular dystrophy R2 Diseases 0.000 description 2
- 101710165009 E3 ubiquitin-protein ligase TRIM13 Proteins 0.000 description 2
- 241001115402 Ebolavirus Species 0.000 description 2
- 108010003751 Elongin Proteins 0.000 description 2
- 102000004662 Elongin Human genes 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 206010016207 Familial Mediterranean fever Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101150096276 HOG1 gene Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102100025449 Homeobox protein SIX5 Human genes 0.000 description 2
- 101000871850 Homo sapiens Bromodomain-containing protein 2 Proteins 0.000 description 2
- 101000983523 Homo sapiens Caspase-9 Proteins 0.000 description 2
- 101000957914 Homo sapiens Death domain-containing protein CRADD Proteins 0.000 description 2
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 2
- 101001034840 Homo sapiens Eukaryotic translation initiation factor 4 gamma 3 Proteins 0.000 description 2
- 101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 description 2
- 101000835959 Homo sapiens Homeobox protein SIX5 Proteins 0.000 description 2
- 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 description 2
- 101100403718 Homo sapiens MYC gene Proteins 0.000 description 2
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 description 2
- 101000752249 Homo sapiens Rho guanine nucleotide exchange factor 3 Proteins 0.000 description 2
- 101000752241 Homo sapiens Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 2
- 101000651509 Homo sapiens Signal recognition particle 19 kDa protein Proteins 0.000 description 2
- 101000819074 Homo sapiens Transcription factor GATA-4 Proteins 0.000 description 2
- 101000795753 Homo sapiens mRNA decay activator protein ZFP36 Proteins 0.000 description 2
- 102000003839 Human Proteins Human genes 0.000 description 2
- 108090000144 Human Proteins Proteins 0.000 description 2
- 241000598171 Human adenovirus sp. Species 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 241000430519 Human rhinovirus sp. Species 0.000 description 2
- 208000031309 Hypertrophic Familial Cardiomyopathy Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 108010021699 I-kappa B Proteins Proteins 0.000 description 2
- 102000008379 I-kappa B Proteins Human genes 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000032420 Latent Infection Diseases 0.000 description 2
- 102000010049 MAP kinase kinase kinase kinase activity proteins Human genes 0.000 description 2
- 108040005742 MAP kinase kinase kinase kinase activity proteins Proteins 0.000 description 2
- 101150022024 MYCN gene Proteins 0.000 description 2
- 102100025169 Max-binding protein MNT Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 101100334382 Mus musculus Fastk gene Proteins 0.000 description 2
- 101100013973 Mus musculus Gata4 gene Proteins 0.000 description 2
- 101100293199 Mus musculus Myc gene Proteins 0.000 description 2
- 206010068871 Myotonic dystrophy Diseases 0.000 description 2
- 108010052185 Myotonin-Protein Kinase Proteins 0.000 description 2
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 2
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 2
- 108700037255 NEDD8-activating enzyme E1 catalytic subunit Proteins 0.000 description 2
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 241000150452 Orthohantavirus Species 0.000 description 2
- 102000016610 Oxidized LDL Receptors Human genes 0.000 description 2
- 102000000470 PDZ domains Human genes 0.000 description 2
- 108050008994 PDZ domains Proteins 0.000 description 2
- 241001631646 Papillomaviridae Species 0.000 description 2
- 101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 2
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 2
- 241000709664 Picornaviridae Species 0.000 description 2
- 102100032442 Protein S100-A8 Human genes 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- 108010046934 Proto-Oncogene Proteins c-hck Proteins 0.000 description 2
- 241000125945 Protoparvovirus Species 0.000 description 2
- 108010009460 RNA Polymerase II Proteins 0.000 description 2
- 102000009572 RNA Polymerase II Human genes 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 102000044126 RNA-Binding Proteins Human genes 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 108090000244 Rat Proteins Proteins 0.000 description 2
- 101100286581 Rattus norvegicus Igf2 gene Proteins 0.000 description 2
- 102100021689 Rho guanine nucleotide exchange factor 3 Human genes 0.000 description 2
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 101150054830 S100A6 gene Proteins 0.000 description 2
- 102000000395 SH3 domains Human genes 0.000 description 2
- 108050008861 SH3 domains Proteins 0.000 description 2
- 101100395426 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sty1 gene Proteins 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 108091061750 Signal recognition particle RNA Proteins 0.000 description 2
- 102100027318 Signal recognition particle subunit SRP68 Human genes 0.000 description 2
- 102100027315 Signal recognition particle subunit SRP72 Human genes 0.000 description 2
- 101710132545 Signal recognition particle subunit SRP72 Proteins 0.000 description 2
- 101710132566 Signal recognition particle subunit srp68 Proteins 0.000 description 2
- 241000713311 Simian immunodeficiency virus Species 0.000 description 2
- 108700031279 Smad7 Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 102100021380 Transcription factor GATA-4 Human genes 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 101150035006 UBA3 gene Proteins 0.000 description 2
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 2
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 2
- 108091023045 Untranslated Region Proteins 0.000 description 2
- 241000713325 Visna/maedi virus Species 0.000 description 2
- 210000001766 X chromosome Anatomy 0.000 description 2
- 210000002593 Y chromosome Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 210000001943 adrenal medulla Anatomy 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 239000004037 angiogenesis inhibitor Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000000074 antisense oligonucleotide Substances 0.000 description 2
- 238000012230 antisense oligonucleotides Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 244000309743 astrovirus Species 0.000 description 2
- 101150036080 at gene Proteins 0.000 description 2
- 201000009563 autosomal recessive limb-girdle muscular dystrophy type 2B Diseases 0.000 description 2
- 206010003883 azoospermia Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 238000001516 cell proliferation assay Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- KGOWNOCWAIJTSZ-DRVNWNPESA-N chickpea clap Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H]1NCCC1)C(C)C)C1=CC=CC=C1 KGOWNOCWAIJTSZ-DRVNWNPESA-N 0.000 description 2
- 238000011490 co-immunoprecipitation assay Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 210000003989 endothelium vascular Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 201000006692 familial hypertrophic cardiomyopathy Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 102000054766 genetic haplotypes Human genes 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 102000053563 human MYC Human genes 0.000 description 2
- 102000047846 human SRP19 Human genes 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 244000052637 human pathogen Species 0.000 description 2
- 210000004754 hybrid cell Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000007813 immunodeficiency Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 238000002991 immunohistochemical analysis Methods 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000037797 influenza A Diseases 0.000 description 2
- 230000017306 interleukin-6 production Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 230000000503 lectinlike effect Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 201000006938 muscular dystrophy Diseases 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 210000004897 n-terminal region Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000001020 neural plate Anatomy 0.000 description 2
- 230000004031 neuronal differentiation Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000004129 prosencephalon Anatomy 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 108010014186 ras Proteins Proteins 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000001608 teratocarcinoma Diseases 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000005029 transcription elongation Effects 0.000 description 2
- 108091006107 transcriptional repressors Proteins 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FLEHQRTTWKDNGI-XTJILODYSA-N (1s,3r)-5-[(2e)-2-[(7ar)-1-[(2s)-5-(cyclopropylamino)pentan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-2-methylidenecyclohexane-1,3-diol Chemical compound C([C@H](C)C1[C@]2(CCCC(/C2CC1)=C\C=C1C[C@@H](O)C(=C)[C@@H](O)C1)C)CCNC1CC1 FLEHQRTTWKDNGI-XTJILODYSA-N 0.000 description 1
- UHEPSJJJMTWUCP-DHDYTCSHSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N UHEPSJJJMTWUCP-DHDYTCSHSA-N 0.000 description 1
- LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
- 101710186714 2-acylglycerol O-acyltransferase 1 Proteins 0.000 description 1
- 108700034601 3 Familial Hypertrophic Cardiomyopathy Proteins 0.000 description 1
- DVGKRPYUFRZAQW-UHFFFAOYSA-N 3 prime Natural products CC(=O)NC1OC(CC(O)C1C(O)C(O)CO)(OC2C(O)C(CO)OC(OC3C(O)C(O)C(O)OC3CO)C2O)C(=O)O DVGKRPYUFRZAQW-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 101150008694 ANXA1 gene Proteins 0.000 description 1
- 101710159080 Aconitate hydratase A Proteins 0.000 description 1
- 101710159078 Aconitate hydratase B Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 208000010370 Adenoviridae Infections Diseases 0.000 description 1
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- 108010002020 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 description 1
- 108091023043 Alu Element Proteins 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 102000004148 Annexin A4 Human genes 0.000 description 1
- 108090000669 Annexin A4 Proteins 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 102000004154 Annexin A6 Human genes 0.000 description 1
- 108090000656 Annexin A6 Proteins 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 description 1
- 108010056594 Avian Proteins Proteins 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
- 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 241000713704 Bovine immunodeficiency virus Species 0.000 description 1
- 241000701822 Bovine papillomavirus Species 0.000 description 1
- 108090000342 C-Type Lectins Proteins 0.000 description 1
- 102000003930 C-Type Lectins Human genes 0.000 description 1
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 102000002110 C2 domains Human genes 0.000 description 1
- 108050009459 C2 domains Proteins 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 101000741929 Caenorhabditis elegans Serine/threonine-protein phosphatase 2A catalytic subunit Proteins 0.000 description 1
- 101100342815 Caenorhabditis elegans lec-1 gene Proteins 0.000 description 1
- 108010042955 Calcineurin Proteins 0.000 description 1
- 102000004631 Calcineurin Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010052500 Calgranulin A Proteins 0.000 description 1
- 102100025580 Calmodulin-1 Human genes 0.000 description 1
- 241000700664 Capripoxvirus Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102100030613 Carboxypeptidase A1 Human genes 0.000 description 1
- 102100030614 Carboxypeptidase A2 Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108090000566 Caspase-9 Proteins 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000005483 Cell Cycle Proteins Human genes 0.000 description 1
- 108010031896 Cell Cycle Proteins Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 101710150820 Cellular tumor antigen p53 Proteins 0.000 description 1
- 102100040268 Cleavage stimulation factor subunit 1 Human genes 0.000 description 1
- 102100040269 Cleavage stimulation factor subunit 2 Human genes 0.000 description 1
- 102100040267 Cleavage stimulation factor subunit 3 Human genes 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108091029523 CpG island Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 208000026292 Cystic Kidney disease Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- -1 DOPE Chemical compound 0.000 description 1
- 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
- 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
- 108700042671 Deleted in Azoospermia 1 Proteins 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102100030012 Deoxyribonuclease-1 Human genes 0.000 description 1
- 241001273416 Didymella arachidicola Species 0.000 description 1
- 102100024099 Disks large homolog 1 Human genes 0.000 description 1
- 108700026667 Drosophila emc Proteins 0.000 description 1
- 102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 description 1
- 108010069091 Dystrophin Proteins 0.000 description 1
- 102000001039 Dystrophin Human genes 0.000 description 1
- 102100030208 Elongin-A Human genes 0.000 description 1
- 102100030209 Elongin-B Human genes 0.000 description 1
- 102100037114 Elongin-C Human genes 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000713730 Equine infectious anemia virus Species 0.000 description 1
- 102100029987 Erbin Human genes 0.000 description 1
- 101100237347 Escherichia coli (strain K12) metN gene Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 101710103508 FK506-binding protein Proteins 0.000 description 1
- 101710104425 FK506-binding protein 2 Proteins 0.000 description 1
- 101710104423 FK506-binding protein 3 Proteins 0.000 description 1
- 101710104333 FK506-binding protein 4 Proteins 0.000 description 1
- 101710104342 FK506-binding protein 5 Proteins 0.000 description 1
- 101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102000011652 Formyl peptide receptors Human genes 0.000 description 1
- 108010076288 Formyl peptide receptors Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000035519 G0 Phase Effects 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 101001035782 Gallus gallus Hemoglobin subunit beta Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 102100036646 Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 101150004849 HCK gene Proteins 0.000 description 1
- 108010010369 HIV Protease Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 102100033079 HLA class II histocompatibility antigen, DM alpha chain Human genes 0.000 description 1
- 108010050568 HLA-DM antigens Proteins 0.000 description 1
- 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 1
- 102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108010087745 Hepatocyte Nuclear Factor 3-beta Proteins 0.000 description 1
- 102000009094 Hepatocyte Nuclear Factor 3-beta Human genes 0.000 description 1
- 102100029284 Hepatocyte nuclear factor 3-beta Human genes 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 102100037848 Heterochromatin protein 1-binding protein 3 Human genes 0.000 description 1
- 102100021467 Histone acetyltransferase type B catalytic subunit Human genes 0.000 description 1
- 101000972916 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000914211 Homo sapiens CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
- 101100007954 Homo sapiens CTCF gene Proteins 0.000 description 1
- 101000984164 Homo sapiens Calmodulin-1 Proteins 0.000 description 1
- 101000772551 Homo sapiens Carboxypeptidase A1 Proteins 0.000 description 1
- 101000891786 Homo sapiens Cleavage stimulation factor subunit 1 Proteins 0.000 description 1
- 101000891801 Homo sapiens Cleavage stimulation factor subunit 3 Proteins 0.000 description 1
- 101000944380 Homo sapiens Cyclin-dependent kinase inhibitor 1 Proteins 0.000 description 1
- 101100498454 Homo sapiens DAZ1 gene Proteins 0.000 description 1
- 101001053984 Homo sapiens Disks large homolog 1 Proteins 0.000 description 1
- 101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 description 1
- 101001115394 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 3 Proteins 0.000 description 1
- 101100501702 Homo sapiens ERBIN gene Proteins 0.000 description 1
- 101001011859 Homo sapiens Elongin-A Proteins 0.000 description 1
- 101001011846 Homo sapiens Elongin-B Proteins 0.000 description 1
- 101000881731 Homo sapiens Elongin-C Proteins 0.000 description 1
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
- 101001025546 Homo sapiens Heterochromatin protein 1-binding protein 3 Proteins 0.000 description 1
- 101000898976 Homo sapiens Histone acetyltransferase type B catalytic subunit Proteins 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 101001008854 Homo sapiens Kelch-like protein 6 Proteins 0.000 description 1
- 101001008857 Homo sapiens Kelch-like protein 7 Proteins 0.000 description 1
- 101001139126 Homo sapiens Krueppel-like factor 6 Proteins 0.000 description 1
- 101001134216 Homo sapiens Macrophage scavenger receptor types I and II Proteins 0.000 description 1
- 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 1
- 101000837517 Homo sapiens NEDD8-activating enzyme E1 catalytic subunit Proteins 0.000 description 1
- 101100080178 Homo sapiens NOD1 gene Proteins 0.000 description 1
- 101000927793 Homo sapiens Neuroepithelial cell-transforming gene 1 protein Proteins 0.000 description 1
- 101000741956 Homo sapiens PRA1 family protein 3 Proteins 0.000 description 1
- 101001060744 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
- 101000878221 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 description 1
- 101001124937 Homo sapiens Pre-mRNA-splicing factor 38B Proteins 0.000 description 1
- 101000685712 Homo sapiens Protein S100-A1 Proteins 0.000 description 1
- 101000869690 Homo sapiens Protein S100-A8 Proteins 0.000 description 1
- 101000869693 Homo sapiens Protein S100-A9 Proteins 0.000 description 1
- 101000801643 Homo sapiens Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 description 1
- 101001075558 Homo sapiens Rho GTPase-activating protein 29 Proteins 0.000 description 1
- 101000635799 Homo sapiens Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Proteins 0.000 description 1
- 101000597662 Homo sapiens Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Proteins 0.000 description 1
- 101000631937 Homo sapiens Sodium- and chloride-dependent glycine transporter 2 Proteins 0.000 description 1
- 101000639975 Homo sapiens Sodium-dependent noradrenaline transporter Proteins 0.000 description 1
- 101000881267 Homo sapiens Spectrin alpha chain, erythrocytic 1 Proteins 0.000 description 1
- 101100152305 Homo sapiens TAB1 gene Proteins 0.000 description 1
- 101100425894 Homo sapiens TPM1 gene Proteins 0.000 description 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 101000798726 Homo sapiens Transmembrane 9 superfamily member 4 Proteins 0.000 description 1
- 101000764260 Homo sapiens Troponin T, cardiac muscle Proteins 0.000 description 1
- 101000772165 Homo sapiens Tubby-related protein 4 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 241000713297 Influenza C virus Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000018427 Iphisa elegans Species 0.000 description 1
- 102100027789 Kelch-like protein 7 Human genes 0.000 description 1
- 108050007394 Kinesin-like protein KIF20B Proteins 0.000 description 1
- 102100020679 Krueppel-like factor 6 Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- 108700012928 MAPK14 Proteins 0.000 description 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
- 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101150003941 Mapk14 gene Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
- 108091006675 Monovalent cation:proton antiporter-2 Proteins 0.000 description 1
- 102100030590 Mothers against decapentaplegic homolog 6 Human genes 0.000 description 1
- 102000014842 Multidrug resistance proteins Human genes 0.000 description 1
- 108050005144 Multidrug resistance proteins Proteins 0.000 description 1
- 101100400865 Mus musculus Abcb1b gene Proteins 0.000 description 1
- 101100340263 Mus musculus Id3 gene Proteins 0.000 description 1
- 101100425896 Mus musculus Tpm1 gene Proteins 0.000 description 1
- 101000801715 Mus musculus Tropomyosin alpha-1 chain Proteins 0.000 description 1
- 241000699667 Mus spretus Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 101001134300 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Multidomain regulatory protein Rv1364c Proteins 0.000 description 1
- 101000615835 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Phosphoserine phosphatase SerB2 Proteins 0.000 description 1
- 101001082202 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Triple specificity protein phosphatase PtpB Proteins 0.000 description 1
- 101001134301 Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) Multidomain regulatory protein MT1410 Proteins 0.000 description 1
- 101100444360 Mycoplasma mycoides subsp. mycoides SC (strain PG1) ecfA1 gene Proteins 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 208000014767 Myeloproliferative disease Diseases 0.000 description 1
- 102100035083 Myoferlin Human genes 0.000 description 1
- 108050006329 Myoferlin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 108010084498 Myosin Heavy Chains Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 102000019148 NF-kappaB-inducing kinase activity proteins Human genes 0.000 description 1
- 108010077854 Natural Killer Cell Receptors Proteins 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- 101100464186 Oryzias latipes pkd1l1 gene Proteins 0.000 description 1
- 101710114693 Outer membrane protein MIP Proteins 0.000 description 1
- 102100038660 PRA1 family protein 3 Human genes 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 101710111198 Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 1
- 101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 1
- 101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 description 1
- 101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 description 1
- 101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 1
- 101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
- 101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 description 1
- 101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 description 1
- 101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 description 1
- 101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 description 1
- 101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 1
- 101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 description 1
- 101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 description 1
- 101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 description 1
- 101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 description 1
- 101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 description 1
- 101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 description 1
- 101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 description 1
- 101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 description 1
- 102000009658 Peptidylprolyl Isomerase Human genes 0.000 description 1
- 108010020062 Peptidylprolyl Isomerase Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 102100026090 Polyadenylate-binding protein 1 Human genes 0.000 description 1
- 101710103012 Polyadenylate-binding protein, cytoplasmic and nuclear Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
- 102000006478 Protein Phosphatase 2 Human genes 0.000 description 1
- 108010058956 Protein Phosphatase 2 Proteins 0.000 description 1
- 102100023097 Protein S100-A1 Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 102000006831 Protein phosphatase 2C Human genes 0.000 description 1
- 108010047313 Protein phosphatase 2C Proteins 0.000 description 1
- 108010010974 Proteolipids Proteins 0.000 description 1
- 102000016202 Proteolipids Human genes 0.000 description 1
- 101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 108700020471 RNA-Binding Proteins Proteins 0.000 description 1
- 101710105008 RNA-binding protein Proteins 0.000 description 1
- 102100030800 Ras suppressor protein 1 Human genes 0.000 description 1
- 101710102668 Ras suppressor protein 1 Proteins 0.000 description 1
- 101000741845 Rattus norvegicus Protein phosphatase 1A Proteins 0.000 description 1
- 101000801718 Rattus norvegicus Tropomyosin alpha-1 chain Proteins 0.000 description 1
- JQYMGXZJTCOARG-UHFFFAOYSA-N Reactive blue 2 Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC(S(O)(=O)=O)=C1 JQYMGXZJTCOARG-UHFFFAOYSA-N 0.000 description 1
- 102100033617 Retinal-specific phospholipid-transporting ATPase ABCA4 Human genes 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 108700025701 Retinoblastoma Genes Proteins 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 102100020899 Rho GTPase-activating protein 29 Human genes 0.000 description 1
- 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 102100030852 Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Human genes 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 102000013674 S-100 Human genes 0.000 description 1
- 108700021018 S100 Proteins 0.000 description 1
- 108091006627 SLC12A9 Proteins 0.000 description 1
- 101700031501 SMAD9 Proteins 0.000 description 1
- 102000001332 SRC Human genes 0.000 description 1
- 108060006706 SRC Proteins 0.000 description 1
- 101000930003 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Diacylglycerol O-acyltransferase 1 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 101710189648 Serine/threonine-protein phosphatase Proteins 0.000 description 1
- 102100035348 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Human genes 0.000 description 1
- 101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 108010051611 Signal Recognition Particle Proteins 0.000 description 1
- 102000013598 Signal recognition particle Human genes 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 1
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 1
- 102100028886 Sodium- and chloride-dependent glycine transporter 2 Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102100037608 Spectrin alpha chain, erythrocytic 1 Human genes 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 241000700568 Suipoxvirus Species 0.000 description 1
- 101000930762 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) Signal recognition particle receptor FtsY Proteins 0.000 description 1
- 108700025695 Suppressor Genes Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- 102100040296 TATA-box-binding protein Human genes 0.000 description 1
- 102100033456 TGF-beta receptor type-1 Human genes 0.000 description 1
- 102000003714 TNF receptor-associated factor 6 Human genes 0.000 description 1
- 108090000009 TNF receptor-associated factor 6 Proteins 0.000 description 1
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 108010083262 Transcription Factor TFIIA Proteins 0.000 description 1
- 102000006289 Transcription Factor TFIIA Human genes 0.000 description 1
- 108010083268 Transcription Factor TFIID Proteins 0.000 description 1
- 102100030246 Transcription factor Sp1 Human genes 0.000 description 1
- 101710085924 Transcription factor Sp1 Proteins 0.000 description 1
- 102000004408 Transcription factor TFIIB Human genes 0.000 description 1
- 108090000941 Transcription factor TFIIB Proteins 0.000 description 1
- 101710121478 Transcriptional repressor CTCF Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 1
- 108010092867 Transforming Growth Factor beta Receptors Proteins 0.000 description 1
- 108010011702 Transforming Growth Factor-beta Type I Receptor Proteins 0.000 description 1
- 102100032466 Transmembrane 9 superfamily member 4 Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004987 Troponin T Human genes 0.000 description 1
- 102100026893 Troponin T, cardiac muscle Human genes 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108091005956 Type II transmembrane proteins Proteins 0.000 description 1
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
- 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 description 1
- 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 description 1
- 208000009443 Vascular Malformations Diseases 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 108700031765 Von Hippel-Lindau Tumor Suppressor Proteins 0.000 description 1
- 108700029634 Y-Linked Genes Proteins 0.000 description 1
- 241000700574 Yatapoxvirus Species 0.000 description 1
- 101150096164 ZNF207 gene Proteins 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- 102100029504 Zinc finger protein RFP Human genes 0.000 description 1
- 101710110903 Zinc finger protein RFP Proteins 0.000 description 1
- ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 description 1
- DPLUDQAYKAQJBI-GWOCEWHOSA-J [H+].[H+].[H+].[H+].[Zn++].[Zn++].N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](Cc1c[n-]cn1)C(O)=O.N[C@@H](Cc1c[n-]cn1)C(O)=O Chemical compound [H+].[H+].[H+].[H+].[Zn++].[Zn++].N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](C[S-])C(O)=O.N[C@@H](Cc1c[n-]cn1)C(O)=O.N[C@@H](Cc1c[n-]cn1)C(O)=O DPLUDQAYKAQJBI-GWOCEWHOSA-J 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 102000035181 adaptor proteins Human genes 0.000 description 1
- 108091005764 adaptor proteins Proteins 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011319 anticancer therapy Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 210000002403 aortic endothelial cell Anatomy 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000035578 autophosphorylation Effects 0.000 description 1
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 101150031642 cam2 gene Proteins 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 101150112018 ced-4 gene Proteins 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 230000007960 cellular response to stress Effects 0.000 description 1
- 230000006364 cellular survival Effects 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 238000004182 chemical digestion Methods 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 238000010293 colony formation assay Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 208000011425 congenital myotonic dystrophy Diseases 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 101150004956 cpr-8 gene Proteins 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007911 de novo DNA methylation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 101150087611 eIF3a gene Proteins 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 210000004265 eukaryotic small ribosome subunit Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 210000004420 female germ cell Anatomy 0.000 description 1
- UJHBVMHOBZBWMX-UHFFFAOYSA-N ferrostatin-1 Chemical compound NC1=CC(C(=O)OCC)=CC=C1NC1CCCCC1 UJHBVMHOBZBWMX-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 210000001703 glandular epithelial cell Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 102000028718 growth factor binding proteins Human genes 0.000 description 1
- 108091009353 growth factor binding proteins Proteins 0.000 description 1
- 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000004730 hepatocarcinogenesis Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 102000046804 human BRD2 Human genes 0.000 description 1
- 108091008044 human SRC Proteins 0.000 description 1
- 210000001182 human Y chromosome Anatomy 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 201000010552 hypertrophic cardiomyopathy 1 Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 208000037799 influenza C Diseases 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 102000028416 insulin-like growth factor binding Human genes 0.000 description 1
- 108091022911 insulin-like growth factor binding Proteins 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 244000000056 intracellular parasite Species 0.000 description 1
- 102000027411 intracellular receptors Human genes 0.000 description 1
- 108091008582 intracellular receptors Proteins 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003246 kidney medulla Anatomy 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 210000004901 leucine-rich repeat Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 230000007040 lung development Effects 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 108091005485 macrophage scavenger receptors Proteins 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000003794 male germ cell Anatomy 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 101150077795 mdr gene Proteins 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000034217 membrane fusion Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000006676 mitochondrial damage Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003349 osteoarthritic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000036281 parasite infection Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 210000000680 phagosome Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 208000015768 polyposis Diseases 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 210000001586 pre-b-lymphocyte Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001948 pro-b lymphocyte Anatomy 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000009696 proliferative response Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000005267 prostate cell Anatomy 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000018883 protein targeting Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028617 response to DNA damage stimulus Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 210000002235 sarcomere Anatomy 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 230000037432 silent mutation Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 101150075711 srp19 gene Proteins 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000003518 stress fiber Anatomy 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 101150032836 tceb-3 gene Proteins 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000005092 tracheal tissue Anatomy 0.000 description 1
- 108010014677 transcription factor TFIIE Proteins 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 230000009752 translational inhibition Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- MDYOLVRUBBJPFM-UHFFFAOYSA-N tropolone Chemical compound OC1=CC=CC=CC1=O MDYOLVRUBBJPFM-UHFFFAOYSA-N 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37713602P | 2002-05-02 | 2002-05-02 | |
| PCT/US2003/013743 WO2004010925A2 (en) | 2002-05-02 | 2003-05-02 | Mammalian genes involved in viral infection and tumor suppression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009240934A Division JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006507807A true JP2006507807A (ja) | 2006-03-09 |
| JP2006507807A5 JP2006507807A5 (enExample) | 2006-09-14 |
Family
ID=31188308
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004524480A Pending JP2006507807A (ja) | 2002-05-02 | 2003-05-02 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
| JP2009240934A Pending JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009240934A Pending JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7691599B2 (enExample) |
| EP (2) | EP1572084A4 (enExample) |
| JP (2) | JP2006507807A (enExample) |
| AU (2) | AU2003234445B2 (enExample) |
| CA (1) | CA2485092A1 (enExample) |
| WO (1) | WO2004010925A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070287684A1 (en) | 2006-05-22 | 2007-12-13 | Irshad Chaudry | Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| WO2009079452A2 (en) * | 2007-12-14 | 2009-06-25 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of hiv infection |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US20110038852A1 (en) * | 2009-06-10 | 2011-02-17 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US9340584B2 (en) | 2011-03-29 | 2016-05-17 | The General Hospital Corporation | Engineered thioredoxin-like fold proteins |
| WO2013172969A1 (en) | 2012-05-15 | 2013-11-21 | The Uab Research Foundation | Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| EP2971030B8 (en) * | 2013-03-14 | 2018-12-05 | Glycobia, Inc | Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes |
| WO2016090362A1 (en) * | 2014-12-05 | 2016-06-09 | Vanderbilt University | Identification of cellular antimicrobial drug targets through interactome analysis |
| EP3262174A4 (en) * | 2015-02-23 | 2018-10-17 | Ionis Pharmaceuticals, Inc. | Compounds and methods for increasing antisense activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2018085208A1 (en) | 2016-11-02 | 2018-05-11 | The Research Foundation For The State University Of New York | Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001520012A (ja) * | 1997-10-10 | 2001-10-30 | バンダービルト ユニバーシティ | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JPH07507201A (ja) | 1992-03-10 | 1995-08-10 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 可変鋳型反応 |
| AU742243B2 (en) * | 1996-04-15 | 2001-12-20 | Vanderbilt University | Mammalian genes involved in viral infection and tumor suppression |
-
2003
- 2003-05-02 EP EP03728671A patent/EP1572084A4/en not_active Ceased
- 2003-05-02 AU AU2003234445A patent/AU2003234445B2/en not_active Ceased
- 2003-05-02 WO PCT/US2003/013743 patent/WO2004010925A2/en not_active Ceased
- 2003-05-02 JP JP2004524480A patent/JP2006507807A/ja active Pending
- 2003-05-02 EP EP10188281A patent/EP2327722A3/en not_active Withdrawn
- 2003-05-02 CA CA002485092A patent/CA2485092A1/en not_active Abandoned
- 2003-05-02 US US10/513,426 patent/US7691599B2/en not_active Expired - Fee Related
-
2009
- 2009-10-19 JP JP2009240934A patent/JP2010011871A/ja active Pending
-
2010
- 2010-02-26 AU AU2010200729A patent/AU2010200729A1/en not_active Withdrawn
- 2010-03-05 US US12/718,619 patent/US20100286251A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001520012A (ja) * | 1997-10-10 | 2001-10-30 | バンダービルト ユニバーシティ | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2327722A2 (en) | 2011-06-01 |
| US20100286251A1 (en) | 2010-11-11 |
| CA2485092A1 (en) | 2004-02-05 |
| WO2004010925A3 (en) | 2007-06-28 |
| JP2010011871A (ja) | 2010-01-21 |
| EP2327722A3 (en) | 2012-11-28 |
| US20070254329A1 (en) | 2007-11-01 |
| EP1572084A4 (en) | 2008-04-30 |
| US7691599B2 (en) | 2010-04-06 |
| WO2004010925A2 (en) | 2004-02-05 |
| AU2010200729A1 (en) | 2010-03-18 |
| EP1572084A2 (en) | 2005-09-14 |
| AU2003234445A1 (en) | 2004-02-16 |
| AU2003234445B2 (en) | 2009-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010011871A (ja) | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 | |
| US6740738B2 (en) | Antibody against hypoxia proteins | |
| JP2001502894A (ja) | ドメイン死アゴニストと相互作用するｂｈ３ | |
| US20090092594A1 (en) | Mammalian genes involved in viral infection and tumor suppression | |
| JPH10513359A (ja) | サイクリン依存性キナーゼＣＤＫ４およびＣＤＫ６のインヒビター、ＩｎＫ４ｃ−ｐ１８およびＩｎＫ４ｄ−ｐ１９、ならびにそれらの使用 | |
| EP1115733A1 (en) | Sequences characteristic of hypoxia-regulated gene transcription | |
| JP2003534809A (ja) | 心臓病のための新規ターゲット遺伝子 | |
| JP2009100780A (ja) | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 | |
| JPH11512294A (ja) | 癌の治療、予防および発見を目的とする腫瘍細胞での蛋白ホスファターゼ２Ｃ−ＰＰ２Ｃα−発現の操作と検出 | |
| US7973156B2 (en) | Hypoxia-regulated genes | |
| US20050112553A1 (en) | Mammalian genes involved in viral infection and tumor suppression | |
| WO2002040667A1 (fr) | Procede pour diagnostiquer et traiter des lesions du cristallin a l'aide du gene crygs et d'un produit codant de celui-ci | |
| EP1001966A1 (en) | A senescence gene and its use in the treatment of cancer and other diseases | |
| KR19990044317A (ko) | 아밀포스파타제2Ｃ - ＰＰ 2Ｃα-발현의 조작 및 검출 | |
| Uwimpuhwe | Molecular analysis of decay accelerating factor as a potential susceptibility factor to developing treatment resistant extraocular muscle involvement in Myasthenia Gravis | |
| WO2003048196A2 (en) | Means and methods for diagnosing and treating craniofacial malformations | |
| ZA200101566B (en) | Sequences characteristic of hypoxia-regulated gene transcription. | |
| JPH09206080A (ja) | ウェルナー症候群の原因遺伝子の存在する領域にある新規な遺伝子、ｗｓ−２、及びその遺伝子がコードするタンパク質 | |
| AU2010201498A1 (en) | Mammalian Genes Involved in Viral Infection and Tumor Suppression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060428 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060428 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090420 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090716 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090724 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091019 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100823 |